G. Steven Burrill
Welcome from the CEO
Flash required to view this video. Download the latest version here
G. Steven BurrillPodcast
![]() |
Hear G. Steven Burrill's vision of healthcare in the year 2020 in a special podcast from The Journal of Life Sciences. |
News
Biotech red hot in July as potential blockbuster M&A deals awake investors from their summer slumber August 01, 2008 | Press Release
Biotech remains upbeat in wake of market turmoil July 01, 2008 | Press Release
Genetic test industry faces tough challenges with consumers, survey finds June 17, 2008 | Press Release
See all News
Michael Keyoung, MD, PhD
DirectorDr. Michael Keyoung joined Burrill & Company in 2007. Prior to joining Burrill & Company, he served as a consultant to venture capital firms and medical devices and biotechnology companies. Previously, Dr. Keyoung was a co-founder of a life science investment partnership in New York and Howard Hughes Medical Institute fellow. Dr. Keyoung received his clinical surgical training at the University of California, San Francisco and biomedical fellowship at Memorial Sloan Kettering Institute and Rockefeller University in New York. As NIH-Medical Scientist Training Program scholarship recipient, Dr. Keyoung received both his M.D. and Ph.D. degrees in Neuroscience and Neurology from Cornell University Weill Medical College and Memorial Sloan-Kettering Cancer Center. Dr. Keyoung has over 35 articles, book chapters, and presentations in publications such as Nature Biotechnology and Nature Medicine. Dr. Keyoung has served on the Board of Overseers at the Weill Medical College of Cornell University and New York County Medical Board of Directors.

.jpg)
.jpg)